Should ethnicity serve as the basis for clinical trial design? Diversity and inclusiveness should remain the guiding principles for clinical trials

Circulation. 2005 Dec 6;112(23):3660-5; discussion 3665-6.
No abstract available

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Black or African American*
  • Clinical Protocols
  • Clinical Trials as Topic / methods*
  • Ethnicity
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Hypertension, Renal
  • Hypolipidemic Agents / therapeutic use
  • Kidney Diseases / complications
  • Kidney Diseases / drug therapy*
  • Myocardial Infarction / prevention & control*
  • Racial Groups

Substances

  • Antihypertensive Agents
  • Hypolipidemic Agents